ROIV – roivant sciences ltd. - common shares (US:NASDAQ)
Stock Stats
News
Roivant Sciences (ROIV) was given a new $40.00 price target by Piper Sandler.
Roivant Sciences (ROIV): A Clinical Trial Win Meets a Phase 3 Failure [Yahoo! Finance]
Ohio governor: Vivek Ramaswamy faces little-known GOP challengers [USA TODAY]
Should Brepocitinib's New Trials and Batoclimab's Setback Require Action From Roivant Sciences (ROIV) Investors? [Yahoo! Finance]
Roivant Sciences Ltd. (ROIV) Discusses Brepocitinib Program Expansion and Phase III Batoclimab Data Update Transcript [Seeking Alpha]
Form 4 Roivant Sciences Ltd. For: Apr 17 Filed by: Oren Ilan
Form 4 Roivant Sciences Ltd. For: Apr 17 Filed by: Epperly Melissa B,
Form 4 Roivant Sciences Ltd. For: Apr 17 Filed by: MOMTAZEE JAMES C
Form 4 Roivant Sciences Ltd. For: Apr 16 Filed by: Gline Matthew
Form 144 Roivant Sciences Ltd. Filed by: Venker Eric
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.